Pasha Announces Share Consolidation, Financing and Restructuring of Debt


Ryan Allway

February 26th, 2020

News


VANCOUVER, British Columbia, Feb. 25, 2020 (GLOBE NEWSWIRE) — Pasha Brands Ltd. (the “Company”) (CSE: CRFT) (OTC:CRFTF) (FSE:ZDD) announces that it plans to consolidate (the “Consolidation”) its common share capital on the basis of one post-Consolidation share for every twelve pre-Consolidation shares. It is anticipated that the Consolidation will reduce the outstanding capital of the Company such that there will be approximately 16,216,612 common shares outstanding.  The Company believes that the Consolidation will make the Company more attractive to financing opportunities, and will allow for the restructuring and settlement of certain existing liabilities.

Financing

Following completion of the Consolidation, the Company intends to offer up to 6,944,444 post-Consolidation units (each, an “Offering Unit”) by way of non-brokered private placement (the “Offering”) at a price of $0.72 per Offering Unit for gross proceeds of up to $5,000,000.  Each Offering Unit will consist of one post-Consolidation common share and one-half of one share purchase warrant which will entitle the holder to acquire one additional post-Consolidation common share at an exercise price of $1.02 for a period of 36 months following closing (the “Closing Date”).

The Company anticipates paying finders fees to certain eligible parties who have assisted by introducing subscribers to the Offering.  All securities issued in connection with the Offering will be subject to a four-month-and-one-day statutory hold period in accordance with applicable securities laws.

Debt Settlement

The Company has reached an agreement with certain arms-length creditors to settle (the “Debt Settlement”) all outstanding obligations related to the acquisition of certain intellectual property associated with the trade name CBD Therapeutics.  The obligations total $2,750,000 and are being settled through the transfer of ownership of 1160988 B.C. Ltd., a wholly-owned subsidiary of the Company which holds the assets related to CBD Therapeutics. In connection with the settlement, the Company has also agreed to release a total of 17,510,072 pre-Consolidation common shares issued in connection with the original acquisition of 1160988 B.C. Ltd. from the terms of a voluntary pooling arrangement, such that they will now become free-trading.

Restructuring of Convertible Debentures

The Company also announces that it intends to seek approval from the holders of outstanding convertible debentures (the “Debentures”) in the aggregate principal amount of $12,261,456 to convert the Debentures into equity of the Company. The Company will seek approval of the holders to issue an aggregate of 12,021,035 units (each, a “Conversion Unit”) at a price of $1.02 per Conversion Unit in full and final settlement of all outstanding obligations due and owing in connection with the Debentures. Each Conversion Unit will consist of one post-Consolidation common share and one share purchase warrant which will entitle the holder to acquire one additional post-Consolidation common share of the Company at an exercise price of $1.20 for a period of 36 months following the Closing Date.

Completion of the Consolidation, the Offering, the Debt Settlement and the restructuring of the Debentures, remains subject to completion of appropriate regulatory filings with the Canadian Securities Exchange.

For further information please contact Patrick Brauckmann at (236) 521-5135 (x426)

Investor Relations Contact
Charles Lee
[email protected]
(236) 521-5132 (x423)

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements.  There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.  Accordingly, readers should not place undue reliance on forward-looking statements.  Pasha disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading